-
公开(公告)号：US11813281B2
公开(公告)日：2023-11-14
申请号：US17413387
申请日：2019-11-25
申请人： AIM ImmunoTech Inc.
IPC分类号： A61K31/713 , A61K47/61 , A61K47/64 , A61P21/06
CPC分类号： A61K31/713 , A61K47/61 , A61K47/645 , A61P21/06
摘要： The present invention relates to methods for treating a subject with myalgic encephalomyelitis/chronic fatigue syndrome symptoms comprising administering a target subject a pharmaceutical composition comprising a therapeutic dsRNA (tdsRNA).
-
公开(公告)号：US12102649B2
公开(公告)日：2024-10-01
申请号：US17769986
申请日：2020-10-22
申请人： AIM ImmunoTech Inc.
发明人： Thomas K. Equels , David R. Strayer
IPC分类号： A61K31/7105 , A61K9/00 , A61K31/713 , A61K35/17 , A61P15/00
CPC分类号： A61K31/7105 , A61K9/0024 , A61K35/17 , A61P15/00 , A61K31/713
摘要： Disclosed is a method for treating endometriosis, preventing endometriosis, or ameliorating a symptom of endometriosis in a subject comprising the step of administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising as an active ingredient a therapeutic dsRNA (tdsRNA).
-
公开(公告)号：US11813279B2
公开(公告)日：2023-11-14
申请号：US16537442
申请日：2019-08-09
申请人： AIM IMMUNOTECH INC.
发明人： David R. Strayer , Thomas K. Equels
IPC分类号： A61K31/713 , A61K38/21 , A61K39/395 , A61P35/00 , A61K9/00 , A61K39/00
CPC分类号： A61K31/713 , A61K9/0019 , A61K38/212 , A61K39/3955 , A61P35/00 , A61K2039/505
摘要： One aspect of this disclosure is directed to a method for treating a cancer in a subject in need thereof by administering to the subject at least a first compound and a second compound together or separately. The first compound is an effective amount of a checkpoint inhibitor optionally with at least one pharmaceutically acceptable carrier. The second compound is an effective amount of an Anti-Tumor Immune Enhancer (ATIE) optionally with at least one pharmaceutically acceptable carrier. The compounds can be administered together or separately.
-
-
搜索结果
3 条记录 (耗时 0.013 秒)
